Sign In

Friday, June 02, 2017 - 8:00 am to Saturday, June 03, 2017 - 12:30 pm
Add to Calendar

Location

Hilton San Diego Bayfront, San Diego, CA

U.S. residents: review the Real ID Act regarding boarding federally regulated commercial aircrafts. Depending on your state of residence, you may need to provide a second form of identification at the airport.

Program Chairs

  • K. Rajender Reddy, MD, FAASLD
  • Mark J. Czaja, MD, FAASLD

Content Providers

  • HoChong Gilles, RN, MS, FNP-C
  • Patrick M. Horne, MSN, ARNP, FNP-BC
  • April G. Morris, FNP

Overview

The 2017 Clinical Hepatology Update will provide a unique opportunity for medical and surgical professionals to receive up-to-date information on critical clinical topics in liver disease from leaders in the fields of hepatology and hepatobiliary surgery.

Presentations will offer clinically relevant information on the diagnosis, management, and treatment of all types of liver disease. In addition, participants will have the opportunity to discuss controversies and treatment strategies commonly seen in clinical practice.

Registration Pricing

  • Member $400
  • Trainee & Assoc. Members $200
  • Non-Member $615
    Any physician, scientist, or researcher with doctoral-level training
    who is not employed by Industry (pharma/device/etc.)
  • Trainee & Assoc. Non-Member $250
    Any physician, scientist or researcher in a training program as certified
    by the director of their training program. 
    This category also includes, but is not limited to, the degrees of
    MS, NP, PA, RN, and other related or comparable degrees.
  • Industry $850
    Any Industry (pharma/device/etc.) employee with or without medical training.

Session I: Recent Advances in Hepatology

Friday, June 2
Moderator: K. Rajender Reddy, MD, FAASLD

  • 8-8:05 am    
    Welcome and Introduction
    K. Rajender Reddy, MD, FAASLD
  • 8:05-8:30 am     
    Non-Invasive Diagnosis and Staging of Liver Disease
    Jayant A. Talwalkar, MD, MPH, FAASLD
  • 8:30-8:55 am     
    Genetic Markers in Liver Disease Diagnosis and Treatment
    Frank Lammert, MD
  • 8:55-9:20 am    
    FXR: What it is and How it Can Be Targeted for the Treatment of Liver Diseases
    Christopher L. Bowlus, MD
  • 9:20-9:45 am    
    Contribution of the Microbiota in Liver Disease and its Therapy
    Bernd Schnabl, MD
  • 9:45-10:05 am     
    Panel Discussion
  • 10:05-10:20 am    
    Break

Session II: Cirrhosis, Portal Hypertension, and Beyond

Friday, June 2
Moderator: HoChong Gilles, RN, MS, FNP-C

  • 10:20-10:45 am     
    Nutritional Issues in Advanced Liver Disease
    Jennifer C. Lai, MD 
  • 10:45-11:10 am   
    What to Do About the Pulmonary Manifestations of Cirrhosis
    Michael B. Fallon, MD, FAASLD
  • 11:10-11:35 am    
    Advances in the Management of Ascites and Variceal Hemorrhage
    Juan G. Abraldes, MD
  • 11:35 am–Noon  
    Care of the Patient with Acute Liver Failure
    Ram M. Subramanian, MD
  • Noon–2:20 pm   
    Panel Discussion
  • 12:20 pm-1:30 pm  
    Lunch
  • Breakout Session (Lunch Served) 
    Preventative Health Strategies in the Outpatient Management of Cirrhosis
    HoChong Gilles, RN, MS, FNP-C and Patrick M. Horne, MSN, ARNP, FNP-BC

Session III: Therapeutics in Liver Disease

Friday, June 2
Moderator: Mark J. Czaja, MD, FAASLD

  • 1:30 pm-1:55 pm     
    Current and Evolving Treatments for Alcoholic Hepatitis
    Michael R. Lucey, MD, FAASLD
  • 1:55-2:20 pm     
    What Can I Treat My NASH Patients With?
    Kathleen E. Corey, MD, MPH, MMSc
  • 2:20-2:45 pm    
    Do We Have A Treatment For Hepatic Fibrosis?
    Natalie J. Torok, MD, MSc
  • 2:45-3:10 pm    
    Emerging Treatments For Cholestatic Liver Diseases
    Saul J. Karpen, MD, PhD, FAASLD
  • 3:10-3:30 pm    
    Discussion
  • 3:30-3:50 pm     
    Break

Session IV: Medical and Surgical Aspects of Advanced Liver Disease

Friday, June 2
Moderator: K. Rajender Reddy, MD, FAASLD

  • 3:50-4:15 pm     
    Controversial Indications for Liver Transplantation: Alcoholic Hepatitis, HCC Outside of Criteria, and Porto-Pulmonary Hypertension
    Michael R. Lucey, MD, FAASLD
  • 4:15-4:40 pm     
    Principles of ICU Care in Advanced Cirrhosis
    Ram M. Subramanian, MD
  • 4:40-5:05 pm  
    Post-Transplant Care of the Recipient: The Role of the Community Gastroenterologist/Hepatologist
    Jayant A. Talwalkar, MD, MPH, FAASLD
  • 5:05-5:30 pm
    Coagulopathy in Liver Disease
    R. Todd Stravitz, MD
  • 5:30-5:50 pm    
    Panel Discussion

Session V: Miscellaneous Liver Diseases

Saturday, June 3
Moderator: Mark J. Czaja, MD, FAASLD

  • 8-8:25 am     
    Wilson Disease: Diagnosis and Uncommon Presentations
    Michael L. Schilsky, MD, FAASLD
  • 8:25-8:50 am     
    Acute on Chronic Liver Failure: Is This a Distinct Entity?
    Patrick S. Kamath, MD
  • 8:50-9:15 am    
    HCC: Who to Screen and How to Treat
    Hashem B. El-Serag, MD, MPH
  • 9:15-9:40 am    
    Pediatric Liver Disease: What A General Gastroenterologist/Hepatologist Should Know
    Saul J. Karpen, MD, PhD, FAASLD
  • 9:40-10 am    
    Discussion
  • 10-10:20 am    
    Break

Session VI: Updates on Viral Hepatitis

Saturday, June 3
Moderator: Patrick M. Horne, MSN, ARNP, FNP-BC 

  • 10:20-10:45 am     
    What Do We Do with the HCV Non-Responder?
    K. Rajender Reddy, MD, FAASLD
  • 10:45-11:10 am    
    Treatment of HCV in Decompensated Cirrhosis: Treat Pre- or Post-Transplant
    K. Rajender Reddy, MD, FAASLD
  • 11:10-11:35 am    
    HBV Therapy: Do We Ever Stop Therapy and When?
    Tram T. Tran, MD, FAASLD
  • 11:35-Noon 
    Hepatitis E: Is it a Concern in the US?
    Timothy J. Davern, MD
  • Noon-12:25 pm   
    Panel Discussion
  • 12:25-12:30 pm    
    Conference Summary and Wrap-Up